Author

Niklas Lutterbach

RWTH Aachen University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Carolin Victoria SchneideriD· 2 shared Rafael KramanniD· 2 shared Rebekka K. SchneideriD· 2 shared Adam BenabidiD· 1 shared Aleksandar V. Kargaliev· 1 shared Alexandru FloreaiD· 1 shared Andreas HoeftiD· 1 shared Anna Bock· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Carolin Victoria SchneiderORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cyclic uremia without kidney injury drives cardiovascular disease with rapid onset of immunosenescence and heart failure

Gideon J L Schaefer, Patrick Droste, Carla Sophie Schikarski, Xinhui Li, Marius Kohl, Niklas Lutterbach, Henriëtte de Loor, Lars Koch, Sylvia Menzel, Ling Zhang, Qingqing Long, Kristian Vogt, Anne-Sophie Andries, Anne Babler, David Schumacher, , Konrad Hoeft

This study establishes a mouse model of cyclic uremia without kidney injury, showing it drives cardiovascular disease and immunosenescence independently of traditional risk factors.

bioRxiv · Sep 30, 2026 · PreprintSystems Biology

Oncodevelopmental plasticity of the skeleton in myeloid neoplasms

Salim Atakhanov, Ian Ghezzi, Hector Tejeda Mora, Lucas Greven, Marta Rizk, Lina Schmidt, Katrin Goetz, Lina Merg, Valeria Solozobova, Adam Benabid, Pia Wanner, Niklas Lutterbach, Aleksandar V. Kargaliev, Mathias Schäfersküpper, Alexandru Florea, , Rebekka K. Schneider

This study identifies a novel mechanism in myelofibrosis where a single mutation drives both bone formation and resorption, revealing THBS1 as a therapeutic target.

bioRxiv · Mar 21, 2026 · PreprintCancer Biology